LATEST
EQT agreed to acquire CleanawaynewNavigator Gas / Navigator HoldingsAlcoa / AliGroupInternational Seaways agreed to acquire BrutonBoston Crest PVT / LQR HouseBrady acquired Productivity Solutions and Services businessJMSB / EFSIVista Equity Partners / PKI Business UnitBluegem Capital Partners / Rispo GroupApax Partners agreed to acquire OdidoGTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire Stockbridge
Open App
Agreement signedAgreed 2 Oct 2024

Eton Pharmaceuticals, Inc. /
Ipsen Biopharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. agrees to buy Ipsen Biopharmaceuticals, Inc.

Buy side: Eton Pharmaceuticals, Inc.
Buy sideEton Pharmaceuticals, Inc.
Target: Ipsen Biopharmaceuticals, Inc.
TargetIpsen Biopharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. · 2 Oct 2024Source
See the source
Buy side: Eton Pharmaceuticals, Inc.
Buy sideEton Pharmaceuticals, Inc.
Target: Ipsen Biopharmaceuticals, Inc.
TargetIpsen Biopharmaceuticals, Inc.
01 / BuyerEton Pharmaceuticals, Inc.
02 / TargetIpsen Biopharmaceuticals, Inc.
Source for the buyer and target: Eton Pharmaceuticals, Inc.

For the buyer and target.

“On October 2, 2024, Eton Pharmaceuticals, Inc. (the "Company or Eton") and Ipsen Biopharmaceuticals, Inc. (“Ipsen”), a subsidiary of Ipsen S.A., entered into an Asset Purchase Agreement (the “Acquired INCRELEX® Product”), whereby the Company agreed to acquire Increlex® (mecasermin injection) from Ipsen.”

Published 18 Nov 2025

Open the source
01

What happened

Eton Pharmaceuticals, Inc. agreed to acquire Ipsen Biopharmaceuticals, Inc. for $22,500 at closing, plus an additional $7,500 for product inventory, according to a filing dated Nov. 18, 2025. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. agrees to buy Ipsen Biopharmaceuticals, Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Eton Pharmaceuticals, Inc.

    The source this page is built from.

    Open the source

  2. Announced

    “Eton Pharmaceuticals, Inc. agrees to buy Ipsen Biopharmaceuticals, Inc. Eton Pharmaceuticals, Inc. agreed to acquire Ipsen Biopharmaceuticals, Inc. for $22,500 at closing, plus an additional $7,500 for product invento…”

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.